Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fd38ff393036b78f4fa402ddeeae2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate |
2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f369407b4efeacd21e457c1933a680f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b631c6bc2ec985855f7894345c4f98f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5aecc72956e537dcaa7982a25495cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306069780c17564fd49aace68cca255f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768fa8fb168bd747ddddac977e66f85a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5253a72d5a5692e55671fea07f969c05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efa9fdac07dfaea51977fd41b8cd436d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b18cd033e22f2bf01bcf2d23cdb9da77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae2d899194b3be376dfeb7e0f68393cb |
publicationDate |
2008-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2007376-A2 |
titleOfInvention |
Therapeutic uses of cannabidiol compounds |
abstract |
The present invention provides the use of a Cannabidiol (CBD) compound for the preparation of a pharmaceutical composition for treatment as well as for the prevention of at least one fundamental parameter affecting a vascular system selected from (a) the cardiovascular system; (b) the peripheral vascular system; or (c) a combination of (a) and (b); as well as pharmaceutical compositions and therapeutic methods for treating the above. A fundamental parameter may include blood/plasma lipid profile; atherosclerosis plaque load; size of heart scar; thickness of heart scar; and cardiac function in general. In accordance with a preferred embodiment the invention concerns treatment of heart scars as well as the preventing the formation of heart scars. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11084770-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040932-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202771-B2 |
priorityDate |
2006-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |